Lynch Casey

Chief Executive Officer at IRLA

Sold, on record
$4.4M
Dollars the filings state
Form 4 sales
3
Latest May 10, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • IRLAIRulya Therapeutics Inc.Chief Executive Officer

Sales by reason

0
Routine
3
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale IRLAPlan not stated
    Feb 3, 2021 2021

    Sold 60,000 shares at $38.49 ($2.3M)

    Lynch Casey, Chief Executive Officer

    Sold 5.5% of holdings ($42.3M position)1M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale IRLAPlan not stated
    Mar 22, 2021 +47 days

    Sold 30,000 shares at $35.59 ($1.1M)

    Lynch Casey, Chief Executive Officer

    Sold 2.9% of holdings ($37M position)1M shares leftFiling

  3. 3 Form 4 sale IRLAPlan not stated
    May 10, 2021 +49 days

    Sold 30,000 shares at $34.58 ($1M)

    Lynch Casey, Chief Executive Officer

    Sold 3% of holdings ($34.9M position)978,774 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Lynch Casey
Source
May 10, 2021May 12, 2021IRLAChief Executive OfficerForm 4 sale30,000$1M3.0%Plan not statedSEC
Mar 22, 2021Mar 23, 2021IRLAChief Executive OfficerForm 4 sale30,000$1.1M2.9%Plan not statedSEC
Feb 3, 2021Feb 3, 2021IRLAChief Executive OfficerForm 4 sale60,000$2.3M5.5%Plan not statedSEC